These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22358740)

  • 1. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.
    Hendriksz CJ; Al-Jawad M; Berger KI; Hawley SM; Lawrence R; Mc Ardle C; Summers CG; Wright E; Braunlin E
    J Inherit Metab Dis; 2013 Mar; 36(2):309-22. PubMed ID: 22358740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.
    Solanki GA; Martin KW; Theroux MC; Lampe C; White KK; Shediac R; Lampe CG; Beck M; Mackenzie WG; Hendriksz CJ; Harmatz PR
    J Inherit Metab Dis; 2013 Mar; 36(2):339-55. PubMed ID: 23385297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience.
    Quijada-Fraile P; Arranz Canales E; Martín-Hernández E; Ballesta-Martínez MJ; Guillén-Navarro E; Pintos-Morell G; Moltó-Abad M; Moreno-Martínez D; García Morillo S; Blasco-Alonso J; Couce ML; Gil Sánchez R; Cortès-Saladelafont E; López Rodríguez MA; García-Silva MT; Morales Conejo M
    Orphanet J Rare Dis; 2021 Nov; 16(1):464. PubMed ID: 34732228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pictorial review of the radiographic skeletal findings in Morquio syndrome (mucopolysaccharidosis type IV).
    Padash S; Obaid H; Henderson RDE; Padash Y; Adams SJ; Miller SF; Babyn P
    Pediatr Radiol; 2023 May; 53(5):971-983. PubMed ID: 36627376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.
    Tomatsu S; Montaño AM; Oikawa H; Smith M; Barrera L; Chinen Y; Thacker MM; Mackenzie WG; Suzuki Y; Orii T
    Curr Pharm Biotechnol; 2011 Jun; 12(6):931-45. PubMed ID: 21506915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing evidence-driven individualized treatment plans within Morquio A Syndrome.
    Clarke LA; Harmatz P; Fong EW
    Mol Genet Metab; 2016 Feb; 117(2):217. PubMed ID: 26877092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elosulfase alfa.
    Haddley K
    Drugs Today (Barc); 2014 Jul; 50(7):475-83. PubMed ID: 25101330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morquio disease (Mucopolysaccharidosis type IV-A): clinical aspects, diagnosis and new treatment with enzyme replacement therapy].
    Politei J; Schenone AB; Guelbert N; Fainboim A; Szlago M
    Arch Argent Pediatr; 2015 Aug; 113(4):359-64. PubMed ID: 26172013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study.
    Ficicioglu C; Matalon DR; Luongo N; Menello C; Kornafel T; Degnan AJ
    Orphanet J Rare Dis; 2020 Nov; 15(1):336. PubMed ID: 33256811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of the oldest known females with mucopolysaccharidosis type IVA (Morquio A syndrome).
    Peretz RH; Flora CH; Adams DJ
    Am J Med Genet A; 2020 Jun; 182(6):1491-1495. PubMed ID: 32216080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia.
    Biswas SN; Patra S; Chakraborty PP; Barman H
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29054894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
    Sawamoto K; Álvarez González JV; Piechnik M; Otero FJ; Couce ML; Suzuki Y; Tomatsu S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis VI.
    Valayannopoulos V; Nicely H; Harmatz P; Turbeville S
    Orphanet J Rare Dis; 2010 Apr; 5():5. PubMed ID: 20385007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International guidelines for the management and treatment of Morquio A syndrome.
    Hendriksz CJ; Berger KI; Giugliani R; Harmatz P; Kampmann C; Mackenzie WG; Raiman J; Villarreal MS; Savarirayan R
    Am J Med Genet A; 2015 Jan; 167A(1):11-25. PubMed ID: 25346323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elosulfase alfa: first global approval.
    Sanford M; Lo JH
    Drugs; 2014 Apr; 74(6):713-8. PubMed ID: 24700469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.